Merck info line swamped over Vioxx recall
177673
Hundreds of patients and physicians have contacted a special information line set up by Merck-Israel in the last few days after the international pharmaceutical company voluntarily withdrew Vioxx - one of the world&#39;s most popular arthritis and acute
280845
Merck &amp; Co.&#39;s campaign to defend itself in the wake of the recall of the pain reliever Vioxx intensified as it placed a package of three full-page ads in seven prominent newspapers beginning last Friday.
392614
Amidst recent prescription drug recalls, health experts have tips for patients to determine the safety of their medications. Merck Pharmaceuticals&#39; September decision to withdraw its widely used arthritis
461726
NEW YORK -- Already wounded by the withdrawal of its Vioxx pain reliever from the market, Merck &amp; Co. must now contend with hundreds of lawsuits over the drug's side effects -- lawsuits that threaten to further damage the company's finances and reputation.
627780
Merck & Co. said on Wednesday it plans  to release data from a study of its recalled arthritis drug  Vioxx at a meeting of specialists later this month.
673213
BOSTON (CBS.MW) -- Merck &amp; Co. shares fell more than 10 percent Monday on a news report that the company may have known for years that Vioxx, the pain reliever it recently withdrew from the market, could cause cardiac problems in some patients.
603689
The decision by Merck & Co. came after a study confirmed simmering concerns that it significantly raises the risk of heart attack and stroke. More than 2 million people take Vioxx worldwide, making this the largest voluntary drug recall in history.
178704
Government questions about &#39;&#39;basic data integrity&quot; derailed publication of a report raising safety concerns about arthritis drug Vioxx on the eve of a
332433
Merck&#39;s (MRK :NYSE - news - research) decision to withdraw its popular arthritis drug Vioxx from the market in late September has raised questions about the process leading up to its regulatory approval in 1999 as well as the importance of subsequent
136905
Federal prosecutors and the Securities and Exchange Commission are investigating Merck &amp; Company in connection with Vioxx, the painkiller that was pulled from the market in late September
421519
(New York-WABC, October 1, 2004) - Two million Americans were taking Vioxx. Now that it&#39;s been recalled, what are those patients supposed to do?
496967
The House Energy and Commerce Committee is investigating how Vioxx was approved and then taken off the market. It has written to Lester Crawford, FDA, and Ray Gilmartin, CEO of Merck, requesting documents about Vioxx.
423926
NEW YORK - As doctors struggle to come to grips with what the withdrawal of Vioxx means for drug safety, the letters pages of the normally sedate New England Journal of Medicine have turned into a battleground.
292172
Merck &amp; Co., the second-largest US drugmaker, lost its AAA credit rating from Standard &amp; Poor&#39;s because of revenue losses and potential liabilities from the company&#39;s September recall of the Vioxx painkiller.
146686
Drug companies rushing to fill the vacuum left by Merck &amp; Co.'s withdrawal of its best-selling arthritis drug Vioxx are flooding the airwaves with competing advertising claims that are bewildering many patients.
173007
The Food and Drug Administration told Merck &amp; Co. that it requires further safety and efficacy data before it will approve its successor drug to now defunct pain reliever Vioxx, the pharmaceutical maker announced Friday.
209879
A Wall Street analysis suggests the Vioxx recall may cost the pharmaceutical firm Merck as much as $18 billion over the next decade.